LBF22603SC01 - Revision history

https://lipidbank.jp/mediawiki/index.php?action=history&feed=atom&title=LBF22603SC01 LBF22603SC01 - Revision history 2026-04-30T15:39:12Z Revision history for this page on the wiki MediaWiki 1.43.0 https://lipidbank.jp/mediawiki/index.php?title=LBF22603SC01&diff=104622&oldid=prev Editor at 00:11, 21 July 2016 2016-07-21T00:11:54Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 09:11, 21 July 2016</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7">Line 7:</td> <td colspan="2" class="diff-lineno">Line 7:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA01030185</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA01030185</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(cis-4,cis-7,cis-10,cis-13,cis-16,cis-19) -Docosahexaenoic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(cis-4,cis-7,cis-10,cis-13,cis-16,cis-19) -Docosahexaenoic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&(4Z,7Z,10Z,13Z,16Z,19Z) -Docosahexaenoic <del style="font-weight: bold; text-decoration: none;">acid&&Cervonic </del>acid&&</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=<ins style="font-weight: bold; text-decoration: none;">&&DHA&&Cervonic acid</ins>&&(4Z,7Z,10Z,13Z,16Z,19Z) -Docosahexaenoic acid&&</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=-44.2 to -44.1 °C</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=-44.2 to -44.1 °C</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Refractive=1.5017 at 26 °C</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Refractive=1.5017 at 26 °C</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF22603SC01&diff=56873&oldid=prev Editor at 10:58, 1 October 2010 2010-10-01T10:58:37Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 19:58, 1 October 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7">Line 7:</td> <td colspan="2" class="diff-lineno">Line 7:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA01030185</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA01030185</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(cis-4,cis-7,cis-10,cis-13,cis-16,cis-19) -Docosahexaenoic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(cis-4,cis-7,cis-10,cis-13,cis-16,cis-19) -Docosahexaenoic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Docosahexaenoic acid&&Cervonic acid&&</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&<ins style="font-weight: bold; text-decoration: none;">(4Z,7Z,10Z,13Z,16Z,19Z) -</ins>Docosahexaenoic acid&&Cervonic acid&&</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=-44.2 to -44.1 °C</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=-44.2 to -44.1 °C</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Refractive=1.5017 at 26 °C</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Refractive=1.5017 at 26 °C</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF22603SC01&diff=56872&oldid=prev Editor at 10:56, 1 October 2010 2010-10-01T10:56:59Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 19:56, 1 October 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7">Line 7:</td> <td colspan="2" class="diff-lineno">Line 7:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA01030185</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA01030185</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(cis-4,cis-7,cis-10,cis-13,cis-16,cis-19) -Docosahexaenoic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(cis-4,cis-7,cis-10,cis-13,cis-16,cis-19) -Docosahexaenoic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Docosahexaenoic acid&&<del style="font-weight: bold; text-decoration: none;">cervonic </del>acid&&</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Docosahexaenoic acid&&<ins style="font-weight: bold; text-decoration: none;">Cervonic </ins>acid&&</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=-44.2 to -44.1 °C</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=-44.2 to -44.1 °C</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Refractive=1.5017 at 26 °C</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Refractive=1.5017 at 26 °C</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF22603SC01&diff=56871&oldid=prev Editor at 10:56, 1 October 2010 2010-10-01T10:56:43Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 19:56, 1 October 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=DFA0224</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=DFA0224</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA01030185</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA01030185</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(4-cis, <del style="font-weight: bold; text-decoration: none;">7</del>-cis<del style="font-weight: bold; text-decoration: none;">, 10</del>-<del style="font-weight: bold; text-decoration: none;">cis</del>, <del style="font-weight: bold; text-decoration: none;">13-</del>cis<del style="font-weight: bold; text-decoration: none;">, 16</del>-<del style="font-weight: bold; text-decoration: none;">cis, </del>19<del style="font-weight: bold; text-decoration: none;">-cis</del>) -Docosahexaenoic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(<ins style="font-weight: bold; text-decoration: none;">cis-</ins>4<ins style="font-weight: bold; text-decoration: none;">,cis</ins>-<ins style="font-weight: bold; text-decoration: none;">7,</ins>cis<ins style="font-weight: bold; text-decoration: none;">-10</ins>,<ins style="font-weight: bold; text-decoration: none;">cis</ins>-<ins style="font-weight: bold; text-decoration: none;">13,</ins>cis-<ins style="font-weight: bold; text-decoration: none;">16</ins>,cis-19) -Docosahexaenoic acid</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Docosahexaenoic acid&&cervonic acid&&</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Docosahexaenoic acid&&cervonic acid&&</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=-44.2 to -44.1 °C</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=-44.2 to -44.1 °C</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF22603SC01&diff=56870&oldid=prev Editor: SysName Corrected 2010-06-03T02:09:57Z

<p>SysName Corrected</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 11:09, 3 June 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=DFA0224</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=DFA0224</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA01030185</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA01030185</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=cis-<del style="font-weight: bold; text-decoration: none;">4</del>, cis-<del style="font-weight: bold; text-decoration: none;">7</del>, <del style="font-weight: bold; text-decoration: none;">cis</del>-<del style="font-weight: bold; text-decoration: none;">10, </del>cis<del style="font-weight: bold; text-decoration: none;">-13</del>, <del style="font-weight: bold; text-decoration: none;">cis</del>-<del style="font-weight: bold; text-decoration: none;">16, </del>cis<del style="font-weight: bold; text-decoration: none;">-19</del>-Docosahexaenoic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=<ins style="font-weight: bold; text-decoration: none;">(4-</ins>cis<ins style="font-weight: bold; text-decoration: none;">, 7</ins>-<ins style="font-weight: bold; text-decoration: none;">cis</ins>, <ins style="font-weight: bold; text-decoration: none;">10-</ins>cis<ins style="font-weight: bold; text-decoration: none;">, 13</ins>-<ins style="font-weight: bold; text-decoration: none;">cis</ins>, <ins style="font-weight: bold; text-decoration: none;">16</ins>-cis, <ins style="font-weight: bold; text-decoration: none;">19</ins>-cis<ins style="font-weight: bold; text-decoration: none;">) </ins>-Docosahexaenoic acid</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Docosahexaenoic acid&&cervonic acid&&</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Docosahexaenoic acid&&cervonic acid&&</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=-44.2 to -44.1 °C</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=-44.2 to -44.1 °C</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF22603SC01&diff=56869&oldid=prev Editor at 21:00, 14 April 2010 2010-04-14T21:00:00Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 06:00, 15 April 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7">Line 7:</td> <td colspan="2" class="diff-lineno">Line 7:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA01030185</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA01030185</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=cis-4, cis-7, cis-10, cis-13, cis-16, cis-19-Docosahexaenoic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=cis-4, cis-7, cis-10, cis-13, cis-16, cis-19-Docosahexaenoic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Docosahexaenoic acid&&cervonic <del style="font-weight: bold; text-decoration: none;">acid&&cis-4, cis-7, cis-10, cis-13, cis-16, cis-19-Docosahexaenoic </del>acid&&</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&Docosahexaenoic acid&&cervonic acid&&</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=-44.2 to -44.1 °C</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Melting Point=-44.2 to -44.1 °C</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Refractive=1.5017 at 26 °C</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Refractive=1.5017 at 26 °C</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF22603SC01&diff=56868&oldid=prev Editor at 10:00, 25 February 2010 2010-02-25T10:00:10Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 19:00, 25 February 2010</td> </tr><tr><td colspan="4" class="diff-notice" lang="en"><div class="mw-diff-empty">(No difference)</div> </td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF22603SC01&diff=56867&oldid=prev Editor at 14:00, 19 February 2010 2010-02-19T14:00:10Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 23:00, 19 February 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l14">Line 14:</td> <td colspan="2" class="diff-lineno">Line 14:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=South African pilchard oil; brain phosphatides; liver lipids of cattle. It is found mainly in fish and marine microorganisms and plants. DHA is also an essential component of the brain, eyes, and other nervous system tissues. Tuna eyeballs are one of the major source .</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=South African pilchard oil; brain phosphatides; liver lipids of cattle. It is found mainly in fish and marine microorganisms and plants. DHA is also an essential component of the brain, eyes, and other nervous system tissues. Tuna eyeballs are one of the major source .</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=Metabolic product of alpha-linolenic acid (9,12,25-18:3). The synthesis of 4,7,10,13,16,19-22:6 (=DHA) occurs via the following reaction sequence [[Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471|{{RelationTable/GetFirstAuthor|Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471}}]]: 9,12,15-18:3 --> 6,9,12,15-18:4 --> 8,11,14,17-20:4 --> 5,8,11,14,17-20:5 --> 7,10,13,16,19-22:5 --> 9,12,15,18,21-24:5 --> 6,9,12,15,18,21-24:6 --> 4,7,10,13,16,19-22:6. According to these pathways the 24-carbon acids that are made in the endoplasmic reticulum move to a site for partial beta-oxidation, which is most likely peroxisomes.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=Metabolic product of <ins style="font-weight: bold; text-decoration: none;"> </ins>alpha -linolenic acid (9,12,25-18:3). The synthesis of 4,7,10,13,16,19-22:6 (=DHA) occurs via the following reaction sequence [[Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471|{{RelationTable/GetFirstAuthor|Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471}}]]: 9,12,15-18:3 --> 6,9,12,15-18:4 --> 8,11,14,17-20:4 --> 5,8,11,14,17-20:5 --> 7,10,13,16,19-22:5 --> 9,12,15,18,21-24:5 --> 6,9,12,15,18,21-24:6 --> 4,7,10,13,16,19-22:6. According to these pathways the 24-carbon acids that are made in the endoplasmic reticulum move to a site for partial beta-oxidation, which is most likely peroxisomes.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=DHA / C22:6n-3 / C22:<del style="font-weight: bold; text-decoration: none;">6omega3</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=DHA / C22:6n-3 / C22:<ins style="font-weight: bold; text-decoration: none;">6 omega 3</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=DHA is one of the n-3 (<del style="font-weight: bold; text-decoration: none;">omega3</del>) fatty acids. It is uniquely rich in neural membranes of retina and brain in mammals. n-3 fatty acid deficiency causes the reduction of DHA level in these tissues and produces reduced learning ability [[Reference:Yamamoto_N:Saitoh_M:Moriuchi_A:Nomura_M:Okuyama_H:,J. Lipid. Res.,1987,28,144|{{RelationTable/GetFirstAuthor|Reference:Yamamoto_N:Saitoh_M:Moriuchi_A:Nomura_M:Okuyama_H:,J. Lipid. Res.,1987,28,144}}]], impaired vision, abnormal electroretinogram [[Reference:Neuringer_M:Connor_WE:Van_Petten_C:Barstad_L:,J. Clin. Invest.,1984,73,272|{{RelationTable/GetFirstAuthor|Reference:Neuringer_M:Connor_WE:Van_Petten_C:Barstad_L:,J. Clin. Invest.,1984,73,272}}]][[Reference:Neuringer_M:Connor_WE:Lin_DS:Barstad_L:Luck_S:,Proc. Natl. Acad. Sci. U. S. A.,1986,83,4021|{{RelationTable/GetFirstAuthor|Reference:Neuringer_M:Connor_WE:Lin_DS:Barstad_L:Luck_S:,Proc. Natl. Acad. Sci. U. S. A.,1986,83,4021}}]] and polydipsia [[Reference:Reisbick_S:Neuringer_M:Hasnain_R:Connor_WE:,Physiol. Behav.,1990,47,315|{{RelationTable/GetFirstAuthor|Reference:Reisbick_S:Neuringer_M:Hasnain_R:Connor_WE:,Physiol. Behav.,1990,47,315}}]]. It is believed to be important for the full development of the nervous system in the fetus and newborn.[[Reference:Okuyama_H:Kobayashi_T:Watanabe_S:,Prog. Lipid Res.,1996,35,409|{{RelationTable/GetFirstAuthor|Reference:Okuyama_H:Kobayashi_T:Watanabe_S:,Prog. Lipid Res.,1996,35,409}}]] <http://www.focusnewsletter.org/dha.htm> <http://www.flax.com/library/Default.htm> Considered, along with EPA, to be the major reason for the beneficial effects of fish oils on the cardiovascular system. <http://www.omegadha.com/pages/dhastory.htm> Anti-inflammatory [[Reference:Tomobe_YI:Morizawa_K:Tsuchida_M:Hibino_H:Nakano_Y:Tanaka_Y:,Lipids,2000,35,61|{{RelationTable/GetFirstAuthor|Reference:Tomobe_YI:Morizawa_K:Tsuchida_M:Hibino_H:Nakano_Y:Tanaka_Y:,Lipids,2000,35,61}}]][[Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211|{{RelationTable/GetFirstAuthor|Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211}}]][[Reference:Shikano_M:Masuzawa_Y:Yazawa_K:,J. Immunol.,1993,150,3525|{{RelationTable/GetFirstAuthor|Reference:Shikano_M:Masuzawa_Y:Yazawa_K:,J. Immunol.,1993,150,3525}}]], anti-thrombotic [[Reference:Nieuwenhuys_CM:Hornstra_G:,Biochim. Biophys. Acta,1998,1390,313|{{RelationTable/GetFirstAuthor|Reference:Nieuwenhuys_CM:Hornstra_G:,Biochim. Biophys. Acta,1998,1390,313}}]], anti-arteriosclerosis [[Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211|{{RelationTable/GetFirstAuthor|Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211}}]][[Reference:Connor_WE:DeFrancesco_CA:Connor:SL:,Ann. N. Y. Acad. Sci.,1993,683,16|{{RelationTable/GetFirstAuthor|Reference:Connor_WE:DeFrancesco_CA:Connor:SL:,Ann. N. Y. Acad. Sci.,1993,683,16}}]] and anti-cancer activities [[Reference:Oshima_M:Takahashi_M:Oshima_H:Tsutsumi_M:Yazawa_K:Sugimura_T:Nishimura_S:Wakabayashi_K:Taketo_MM:,Carcinogenesis,1995,16,2605|{{RelationTable/GetFirstAuthor|Reference:Oshima_M:Takahashi_M:Oshima_H:Tsutsumi_M:Yazawa_K:Sugimura_T:Nishimura_S:Wakabayashi_K:Taketo_MM:,Carcinogenesis,1995,16,2605}}]][[Reference:Takahashi_M:Minamoto_T:Yamashita_N:Kato_T:Yazawa_K:Esumi_H:,Cancer Lett.,1994,83,177|{{RelationTable/GetFirstAuthor|Reference:Takahashi_M:Minamoto_T:Yamashita_N:Kato_T:Yazawa_K:Esumi_H:,Cancer Lett.,1994,83,177}}]] have been reported. Production of bioactive metabolites, eicosanoids, is suppressed by DHA. DHA can be also involved in the modulation of membrane structures [[Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1645|{{RelationTable/GetFirstAuthor|Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1645}}]][[Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1635|{{RelationTable/GetFirstAuthor|Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1635}}]].</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=DHA is one of the n-3 ( <ins style="font-weight: bold; text-decoration: none;">omega 3</ins>) fatty acids. It is uniquely rich in neural membranes of retina and brain in mammals. n-3 fatty acid deficiency causes the reduction of DHA level in these tissues and produces reduced learning ability [[Reference:Yamamoto_N:Saitoh_M:Moriuchi_A:Nomura_M:Okuyama_H:,J. Lipid. Res.,1987,28,144|{{RelationTable/GetFirstAuthor|Reference:Yamamoto_N:Saitoh_M:Moriuchi_A:Nomura_M:Okuyama_H:,J. Lipid. Res.,1987,28,144}}]], impaired vision, abnormal electroretinogram [[Reference:Neuringer_M:Connor_WE:Van_Petten_C:Barstad_L:,J. Clin. Invest.,1984,73,272|{{RelationTable/GetFirstAuthor|Reference:Neuringer_M:Connor_WE:Van_Petten_C:Barstad_L:,J. Clin. Invest.,1984,73,272}}]][[Reference:Neuringer_M:Connor_WE:Lin_DS:Barstad_L:Luck_S:,Proc. Natl. Acad. Sci. U. S. A.,1986,83,4021|{{RelationTable/GetFirstAuthor|Reference:Neuringer_M:Connor_WE:Lin_DS:Barstad_L:Luck_S:,Proc. Natl. Acad. Sci. U. S. A.,1986,83,4021}}]] and polydipsia [[Reference:Reisbick_S:Neuringer_M:Hasnain_R:Connor_WE:,Physiol. Behav.,1990,47,315|{{RelationTable/GetFirstAuthor|Reference:Reisbick_S:Neuringer_M:Hasnain_R:Connor_WE:,Physiol. Behav.,1990,47,315}}]]. It is believed to be important for the full development of the nervous system in the fetus and newborn.[[Reference:Okuyama_H:Kobayashi_T:Watanabe_S:,Prog. Lipid Res.,1996,35,409|{{RelationTable/GetFirstAuthor|Reference:Okuyama_H:Kobayashi_T:Watanabe_S:,Prog. Lipid Res.,1996,35,409}}]] <http://www.focusnewsletter.org/dha.htm> <http://www.flax.com/library/Default.htm> Considered, along with EPA, to be the major reason for the beneficial effects of fish oils on the cardiovascular system. <http://www.omegadha.com/pages/dhastory.htm> Anti-inflammatory [[Reference:Tomobe_YI:Morizawa_K:Tsuchida_M:Hibino_H:Nakano_Y:Tanaka_Y:,Lipids,2000,35,61|{{RelationTable/GetFirstAuthor|Reference:Tomobe_YI:Morizawa_K:Tsuchida_M:Hibino_H:Nakano_Y:Tanaka_Y:,Lipids,2000,35,61}}]][[Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211|{{RelationTable/GetFirstAuthor|Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211}}]][[Reference:Shikano_M:Masuzawa_Y:Yazawa_K:,J. Immunol.,1993,150,3525|{{RelationTable/GetFirstAuthor|Reference:Shikano_M:Masuzawa_Y:Yazawa_K:,J. Immunol.,1993,150,3525}}]], anti-thrombotic [[Reference:Nieuwenhuys_CM:Hornstra_G:,Biochim. Biophys. Acta,1998,1390,313|{{RelationTable/GetFirstAuthor|Reference:Nieuwenhuys_CM:Hornstra_G:,Biochim. Biophys. Acta,1998,1390,313}}]], anti-arteriosclerosis [[Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211|{{RelationTable/GetFirstAuthor|Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211}}]][[Reference:Connor_WE:DeFrancesco_CA:Connor:SL:,Ann. N. Y. Acad. Sci.,1993,683,16|{{RelationTable/GetFirstAuthor|Reference:Connor_WE:DeFrancesco_CA:Connor:SL:,Ann. N. Y. Acad. Sci.,1993,683,16}}]] and anti-cancer activities [[Reference:Oshima_M:Takahashi_M:Oshima_H:Tsutsumi_M:Yazawa_K:Sugimura_T:Nishimura_S:Wakabayashi_K:Taketo_MM:,Carcinogenesis,1995,16,2605|{{RelationTable/GetFirstAuthor|Reference:Oshima_M:Takahashi_M:Oshima_H:Tsutsumi_M:Yazawa_K:Sugimura_T:Nishimura_S:Wakabayashi_K:Taketo_MM:,Carcinogenesis,1995,16,2605}}]][[Reference:Takahashi_M:Minamoto_T:Yamashita_N:Kato_T:Yazawa_K:Esumi_H:,Cancer Lett.,1994,83,177|{{RelationTable/GetFirstAuthor|Reference:Takahashi_M:Minamoto_T:Yamashita_N:Kato_T:Yazawa_K:Esumi_H:,Cancer Lett.,1994,83,177}}]] have been reported. Production of bioactive metabolites, eicosanoids, is suppressed by DHA. DHA can be also involved in the modulation of membrane structures [[Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1645|{{RelationTable/GetFirstAuthor|Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1645}}]][[Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1635|{{RelationTable/GetFirstAuthor|Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1635}}]].</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF22603SC01&diff=56866&oldid=prev Editor at 14:00, 19 February 2010 2010-02-19T14:00:00Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 23:00, 19 February 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l14">Line 14:</td> <td colspan="2" class="diff-lineno">Line 14:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=South African pilchard oil; brain phosphatides; liver lipids of cattle. It is found mainly in fish and marine microorganisms and plants. DHA is also an essential component of the brain, eyes, and other nervous system tissues. Tuna eyeballs are one of the major source .</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=South African pilchard oil; brain phosphatides; liver lipids of cattle. It is found mainly in fish and marine microorganisms and plants. DHA is also an essential component of the brain, eyes, and other nervous system tissues. Tuna eyeballs are one of the major source .</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=Metabolic product of <del style="font-weight: bold; text-decoration: none;"><FONT FACE="Symbol">a</FONT></del>-linolenic acid (9,12,25-18:3). The synthesis of 4,7,10,13,16,19-22:6 (=DHA) occurs via the following reaction sequence [[Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471|{{RelationTable/GetFirstAuthor|Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471}}]]: 9,12,15-18:3 --> 6,9,12,15-18:4 --> 8,11,14,17-20:4 --> 5,8,11,14,17-20:5 --> 7,10,13,16,19-22:5 --> 9,12,15,18,21-24:5 --> 6,9,12,15,18,21-24:6 --> 4,7,10,13,16,19-22:6. According to these pathways the 24-carbon acids that are made in the endoplasmic reticulum move to a site for partial beta-oxidation, which is most likely peroxisomes.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=Metabolic product of <ins style="font-weight: bold; text-decoration: none;">alpha</ins>-linolenic acid (9,12,25-18:3). The synthesis of 4,7,10,13,16,19-22:6 (=DHA) occurs via the following reaction sequence [[Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471|{{RelationTable/GetFirstAuthor|Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471}}]]: 9,12,15-18:3 --> 6,9,12,15-18:4 --> 8,11,14,17-20:4 --> 5,8,11,14,17-20:5 --> 7,10,13,16,19-22:5 --> 9,12,15,18,21-24:5 --> 6,9,12,15,18,21-24:6 --> 4,7,10,13,16,19-22:6. According to these pathways the 24-carbon acids that are made in the endoplasmic reticulum move to a site for partial beta-oxidation, which is most likely peroxisomes.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=DHA / C22:6n-3 / C22:<del style="font-weight: bold; text-decoration: none;">6<FONT FACE="Symbol">w</FONT>3</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=DHA / C22:6n-3 / C22:<ins style="font-weight: bold; text-decoration: none;">6omega3</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=DHA is one of the n-3 (<del style="font-weight: bold; text-decoration: none;"><FONT FACE="Symbol">w</FONT>3</del>) fatty acids. It is uniquely rich in neural membranes of retina and brain in mammals. n-3 fatty acid deficiency causes the reduction of DHA level in these tissues and produces reduced learning ability [[Reference:Yamamoto_N:Saitoh_M:Moriuchi_A:Nomura_M:Okuyama_H:,J. Lipid. Res.,1987,28,144|{{RelationTable/GetFirstAuthor|Reference:Yamamoto_N:Saitoh_M:Moriuchi_A:Nomura_M:Okuyama_H:,J. Lipid. Res.,1987,28,144}}]], impaired vision, abnormal electroretinogram [[Reference:Neuringer_M:Connor_WE:Van_Petten_C:Barstad_L:,J. Clin. Invest.,1984,73,272|{{RelationTable/GetFirstAuthor|Reference:Neuringer_M:Connor_WE:Van_Petten_C:Barstad_L:,J. Clin. Invest.,1984,73,272}}]][[Reference:Neuringer_M:Connor_WE:Lin_DS:Barstad_L:Luck_S:,Proc. Natl. Acad. Sci. U. S. A.,1986,83,4021|{{RelationTable/GetFirstAuthor|Reference:Neuringer_M:Connor_WE:Lin_DS:Barstad_L:Luck_S:,Proc. Natl. Acad. Sci. U. S. A.,1986,83,4021}}]] and polydipsia [[Reference:Reisbick_S:Neuringer_M:Hasnain_R:Connor_WE:,Physiol. Behav.,1990,47,315|{{RelationTable/GetFirstAuthor|Reference:Reisbick_S:Neuringer_M:Hasnain_R:Connor_WE:,Physiol. Behav.,1990,47,315}}]]. It is believed to be important for the full development of the nervous system in the fetus and newborn.[[Reference:Okuyama_H:Kobayashi_T:Watanabe_S:,Prog. Lipid Res.,1996,35,409|{{RelationTable/GetFirstAuthor|Reference:Okuyama_H:Kobayashi_T:Watanabe_S:,Prog. Lipid Res.,1996,35,409}}]] <http://www.focusnewsletter.org/dha.htm> <http://www.flax.com/library/Default.htm> Considered, along with EPA, to be the major reason for the beneficial effects of fish oils on the cardiovascular system. <http://www.omegadha.com/pages/dhastory.htm> Anti-inflammatory [[Reference:Tomobe_YI:Morizawa_K:Tsuchida_M:Hibino_H:Nakano_Y:Tanaka_Y:,Lipids,2000,35,61|{{RelationTable/GetFirstAuthor|Reference:Tomobe_YI:Morizawa_K:Tsuchida_M:Hibino_H:Nakano_Y:Tanaka_Y:,Lipids,2000,35,61}}]][[Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211|{{RelationTable/GetFirstAuthor|Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211}}]][[Reference:Shikano_M:Masuzawa_Y:Yazawa_K:,J. Immunol.,1993,150,3525|{{RelationTable/GetFirstAuthor|Reference:Shikano_M:Masuzawa_Y:Yazawa_K:,J. Immunol.,1993,150,3525}}]], anti-thrombotic [[Reference:Nieuwenhuys_CM:Hornstra_G:,Biochim. Biophys. Acta,1998,1390,313|{{RelationTable/GetFirstAuthor|Reference:Nieuwenhuys_CM:Hornstra_G:,Biochim. Biophys. Acta,1998,1390,313}}]], anti-arteriosclerosis [[Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211|{{RelationTable/GetFirstAuthor|Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211}}]][[Reference:Connor_WE:DeFrancesco_CA:Connor:SL:,Ann. N. Y. Acad. Sci.,1993,683,16|{{RelationTable/GetFirstAuthor|Reference:Connor_WE:DeFrancesco_CA:Connor:SL:,Ann. N. Y. Acad. Sci.,1993,683,16}}]] and anti-cancer activities [[Reference:Oshima_M:Takahashi_M:Oshima_H:Tsutsumi_M:Yazawa_K:Sugimura_T:Nishimura_S:Wakabayashi_K:Taketo_MM:,Carcinogenesis,1995,16,2605|{{RelationTable/GetFirstAuthor|Reference:Oshima_M:Takahashi_M:Oshima_H:Tsutsumi_M:Yazawa_K:Sugimura_T:Nishimura_S:Wakabayashi_K:Taketo_MM:,Carcinogenesis,1995,16,2605}}]][[Reference:Takahashi_M:Minamoto_T:Yamashita_N:Kato_T:Yazawa_K:Esumi_H:,Cancer Lett.,1994,83,177|{{RelationTable/GetFirstAuthor|Reference:Takahashi_M:Minamoto_T:Yamashita_N:Kato_T:Yazawa_K:Esumi_H:,Cancer Lett.,1994,83,177}}]] have been reported. Production of bioactive metabolites, eicosanoids, is suppressed by DHA. DHA can be also involved in the modulation of membrane structures [[Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1645|{{RelationTable/GetFirstAuthor|Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1645}}]][[Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1635|{{RelationTable/GetFirstAuthor|Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1635}}]].</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=DHA is one of the n-3 (<ins style="font-weight: bold; text-decoration: none;">omega3</ins>) fatty acids. It is uniquely rich in neural membranes of retina and brain in mammals. n-3 fatty acid deficiency causes the reduction of DHA level in these tissues and produces reduced learning ability [[Reference:Yamamoto_N:Saitoh_M:Moriuchi_A:Nomura_M:Okuyama_H:,J. Lipid. Res.,1987,28,144|{{RelationTable/GetFirstAuthor|Reference:Yamamoto_N:Saitoh_M:Moriuchi_A:Nomura_M:Okuyama_H:,J. Lipid. Res.,1987,28,144}}]], impaired vision, abnormal electroretinogram [[Reference:Neuringer_M:Connor_WE:Van_Petten_C:Barstad_L:,J. Clin. Invest.,1984,73,272|{{RelationTable/GetFirstAuthor|Reference:Neuringer_M:Connor_WE:Van_Petten_C:Barstad_L:,J. Clin. Invest.,1984,73,272}}]][[Reference:Neuringer_M:Connor_WE:Lin_DS:Barstad_L:Luck_S:,Proc. Natl. Acad. Sci. U. S. A.,1986,83,4021|{{RelationTable/GetFirstAuthor|Reference:Neuringer_M:Connor_WE:Lin_DS:Barstad_L:Luck_S:,Proc. Natl. Acad. Sci. U. S. A.,1986,83,4021}}]] and polydipsia [[Reference:Reisbick_S:Neuringer_M:Hasnain_R:Connor_WE:,Physiol. Behav.,1990,47,315|{{RelationTable/GetFirstAuthor|Reference:Reisbick_S:Neuringer_M:Hasnain_R:Connor_WE:,Physiol. Behav.,1990,47,315}}]]. It is believed to be important for the full development of the nervous system in the fetus and newborn.[[Reference:Okuyama_H:Kobayashi_T:Watanabe_S:,Prog. Lipid Res.,1996,35,409|{{RelationTable/GetFirstAuthor|Reference:Okuyama_H:Kobayashi_T:Watanabe_S:,Prog. Lipid Res.,1996,35,409}}]] <http://www.focusnewsletter.org/dha.htm> <http://www.flax.com/library/Default.htm> Considered, along with EPA, to be the major reason for the beneficial effects of fish oils on the cardiovascular system. <http://www.omegadha.com/pages/dhastory.htm> Anti-inflammatory [[Reference:Tomobe_YI:Morizawa_K:Tsuchida_M:Hibino_H:Nakano_Y:Tanaka_Y:,Lipids,2000,35,61|{{RelationTable/GetFirstAuthor|Reference:Tomobe_YI:Morizawa_K:Tsuchida_M:Hibino_H:Nakano_Y:Tanaka_Y:,Lipids,2000,35,61}}]][[Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211|{{RelationTable/GetFirstAuthor|Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211}}]][[Reference:Shikano_M:Masuzawa_Y:Yazawa_K:,J. Immunol.,1993,150,3525|{{RelationTable/GetFirstAuthor|Reference:Shikano_M:Masuzawa_Y:Yazawa_K:,J. Immunol.,1993,150,3525}}]], anti-thrombotic [[Reference:Nieuwenhuys_CM:Hornstra_G:,Biochim. Biophys. Acta,1998,1390,313|{{RelationTable/GetFirstAuthor|Reference:Nieuwenhuys_CM:Hornstra_G:,Biochim. Biophys. Acta,1998,1390,313}}]], anti-arteriosclerosis [[Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211|{{RelationTable/GetFirstAuthor|Reference:Horrocks_LA:Yeo_YK:,Pharmacol. Res.,1999,40,211}}]][[Reference:Connor_WE:DeFrancesco_CA:Connor:SL:,Ann. N. Y. Acad. Sci.,1993,683,16|{{RelationTable/GetFirstAuthor|Reference:Connor_WE:DeFrancesco_CA:Connor:SL:,Ann. N. Y. Acad. Sci.,1993,683,16}}]] and anti-cancer activities [[Reference:Oshima_M:Takahashi_M:Oshima_H:Tsutsumi_M:Yazawa_K:Sugimura_T:Nishimura_S:Wakabayashi_K:Taketo_MM:,Carcinogenesis,1995,16,2605|{{RelationTable/GetFirstAuthor|Reference:Oshima_M:Takahashi_M:Oshima_H:Tsutsumi_M:Yazawa_K:Sugimura_T:Nishimura_S:Wakabayashi_K:Taketo_MM:,Carcinogenesis,1995,16,2605}}]][[Reference:Takahashi_M:Minamoto_T:Yamashita_N:Kato_T:Yazawa_K:Esumi_H:,Cancer Lett.,1994,83,177|{{RelationTable/GetFirstAuthor|Reference:Takahashi_M:Minamoto_T:Yamashita_N:Kato_T:Yazawa_K:Esumi_H:,Cancer Lett.,1994,83,177}}]] have been reported. Production of bioactive metabolites, eicosanoids, is suppressed by DHA. DHA can be also involved in the modulation of membrane structures [[Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1645|{{RelationTable/GetFirstAuthor|Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1645}}]][[Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1635|{{RelationTable/GetFirstAuthor|Reference:Applegate_KR:Glomset_JA:,J. Lipid. Res.,1991,32,1635}}]].</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td></tr>  </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF22603SC01&diff=56865&oldid=prev Editor at 16:30, 26 January 2010 2010-01-26T16:30:00Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 01:30, 27 January 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l12">Line 12:</td> <td colspan="2" class="diff-lineno">Line 12:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Solubility=soluble in benzene, chloroform, methyl alcohol, ether and petroleum ether.[[Reference:Klenk_E:Bongard_W:,Hoppe Seylers Z. Physiol. Chem.,1952,291,104|{{RelationTable/GetFirstAuthor|Reference:Klenk_E:Bongard_W:,Hoppe Seylers Z. Physiol. Chem.,1952,291,104}}]][[Reference:Klenk_E:Lindlar_F:,Hoppe Seylers Z. Physiol. Chem.,1955,299,74|{{RelationTable/GetFirstAuthor|Reference:Klenk_E:Lindlar_F:,Hoppe Seylers Z. Physiol. Chem.,1955,299,74}}]][[Reference:Whitcutt_JM:,Biochem. J.,1957,67,60|{{RelationTable/GetFirstAuthor|Reference:Whitcutt_JM:,Biochem. J.,1957,67,60}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Solubility=soluble in benzene, chloroform, methyl alcohol, ether and petroleum ether.[[Reference:Klenk_E:Bongard_W:,Hoppe Seylers Z. Physiol. Chem.,1952,291,104|{{RelationTable/GetFirstAuthor|Reference:Klenk_E:Bongard_W:,Hoppe Seylers Z. Physiol. Chem.,1952,291,104}}]][[Reference:Klenk_E:Lindlar_F:,Hoppe Seylers Z. Physiol. Chem.,1955,299,74|{{RelationTable/GetFirstAuthor|Reference:Klenk_E:Lindlar_F:,Hoppe Seylers Z. Physiol. Chem.,1955,299,74}}]][[Reference:Whitcutt_JM:,Biochem. J.,1957,67,60|{{RelationTable/GetFirstAuthor|Reference:Whitcutt_JM:,Biochem. J.,1957,67,60}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chromatograms=Gas liquid chromatogram {{Image200|LBF22603SC01CH0002.gif}} (provided by Dr. Akiko Horiuchi).</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chromatograms=Gas liquid chromatogram {{Image200|LBF22603SC01CH0002.gif}} (provided by Dr. Akiko Horiuchi).</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Source=South African pilchard oil; brain phosphatides; liver lipids of cattle. It is found mainly in fish and marine microorganisms and plants. DHA is also an essential component of the brain, eyes, and other nervous system tissues. Tuna eyeballs are one of the major source .</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Source=South African pilchard oil; brain phosphatides; liver lipids of cattle. It is found mainly in fish and marine microorganisms and plants. DHA is also an essential component of the brain, eyes, and other nervous system tissues. Tuna eyeballs are one of the major source <ins style="font-weight: bold; text-decoration: none;"></ins>.</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=Metabolic product of <FONT FACE="Symbol">a</FONT>-linolenic acid (9,12,25-18:3). The synthesis of 4,7,10,13,16,19-22:6 (=DHA) occurs via the following reaction sequence [[Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471|{{RelationTable/GetFirstAuthor|Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471}}]]: 9,12,15-18:3 --> 6,9,12,15-18:4 --> 8,11,14,17-20:4 --> 5,8,11,14,17-20:5 --> 7,10,13,16,19-22:5 --> 9,12,15,18,21-24:5 --> 6,9,12,15,18,21-24:6 --> 4,7,10,13,16,19-22:6. According to these pathways the 24-carbon acids that are made in the endoplasmic reticulum move to a site for partial beta-oxidation, which is most likely peroxisomes.</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=Metabolic product of <FONT FACE="Symbol">a</FONT>-linolenic acid (9,12,25-18:3). The synthesis of 4,7,10,13,16,19-22:6 (=DHA) occurs via the following reaction sequence [[Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471|{{RelationTable/GetFirstAuthor|Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471}}]]: 9,12,15-18:3 --> 6,9,12,15-18:4 --> 8,11,14,17-20:4 --> 5,8,11,14,17-20:5 --> 7,10,13,16,19-22:5 --> 9,12,15,18,21-24:5 --> 6,9,12,15,18,21-24:6 --> 4,7,10,13,16,19-22:6. According to these pathways the 24-carbon acids that are made in the endoplasmic reticulum move to a site for partial beta-oxidation, which is most likely peroxisomes.</div></td></tr>  </table>

Editor